Search results for "ffpe challenges"

The 1290 Infinity II Method Development System is a high-performance UHPLC method development instrument that provides maximum flexibility and performance to solve even the most complex method development challenges. Use this advanced method development system to screen over 1300 different sets of LC separation conditions automatically in a single campaign at pressures up to 1300 bar with up to 26 different mobile phases and…

At QPS, we realize that in today’s late stage drug development space you face many challenges.  With our deep experience and broad global presence, QPS is in an excellent position to offer solutions to all of the above needs. With its site management & monitoring teams operating from 30 locations on three continents (Asia/Pacific, USA, and Europe), QPS has become a new strong player in Phase II/IV clinical research services.…

The VENTANA MMR RxDx Panel is the first and only immunohistochemistry-based assay approved to identify endometrial carcinoma patients eligible for treatment with JEMPERLI (dostarlimab).